Clinical performances of galactosyl hydroxylysine, pyridinoline, and deoxypyridinoline in postmenopausal osteoporosis

Journal of Clinical Endocrinology and Metabolism

Volumn 81, Issue 2, 1996, Pages 542-546

  Bettica, P ^a,e   Taylor, A K ^a   Talbot, J ^a   Moro, L ^b   Talamini, R ^c   Baylink, D J ^a,d  

^a Jerry L Pettis Memorial VA Medical Center   (United States)

^b UNIVERSITY OF TRIESTE   (Italy)

^c CENTRO DI RIFERIMENTO ONCOLOGICO   (Italy)

^d LOMA LINDA UNIVERSITY   (United States)

^e UNIVERSITY OF MILAN   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

BIOCHEMICAL MARKER; GALACTOSE; HYDROXYLYSINE; HYDROXYPROLINE; PYRIDINE DERIVATIVE;

AGED; ARTICLE; BONE DENSITY; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; CREATININE CLEARANCE; DIAGNOSTIC ACCURACY; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; KIDNEY FUNCTION TEST; LUMBAR SPINE; MAJOR CLINICAL STUDY; OSTEOLYSIS; POSTMENOPAUSE OSTEOPOROSIS; PRIORITY JOURNAL; URINARY EXCRETION;

EID: 0030062747     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.81.2.542     Document Type: Article

References (25)

1. Nimmi ME. 1974 Collagen: its structure, and function in normal and pathological tissues. Semin Arthritis Rheum. 4:95-150.
2. Reid KBM. 1974 A collagen-like amino acid sequence in a polypeptide chain of human C 1q (a sub-component of the first component of complement). Biochem J. 141:189-208.
3. Pinnell SR, Fox R, Krane SM. 1971 Human collagens: differences in glycosilated hydroxylysines in skin and bone. Biochim Biophys Acta. 239:119-122.
4. Krane SM, Kantrowitz FG, Byrne M, Pinnell SR, Singer FR. 1977 Urinary excretion of hydroxylysine and its glycosides as an index of collagen degradation. J Clin Invest. 59:819-827.
5. Eyre DR, Koob TJ, Van Ness KP. 1984 Quantification of hydroxypyridinium crosslinks in collagen by high-performance liquid chromatography. Anal Biochem. 137:380-388.
6. Weiss PH, Klein L. 1969 The quantitative relationship of urinary peptide hydroxyproline excretion to collagen degradation. J Clin Invest. 48:1-10.
7. Efron ML, Bixby EM, Pryles CV. 1965 Hydroxyprolinemia. II A rare metabolic disease due to deficiency of the enzyme "hydroxyproline oxidase(Equation Presented). N Engl J Med. 272:1299-1309.
8. Robins SP. 1982 Turnover of collagen. In: Weiss J, Jayson MIV, eds. Collagen in Health and Disease. London: Churchill Livingstone; pp 160-178.
9. Bettica P, Moro L, Robins SP, Taylor AK, Talbot J, Singer FR, Baylink DJ. 1992 Bone-resorption markers galactosyl hydroxylysine, pyridinium crosslinks and hydroxyproline compared. Clin Chem. 38:2313-2318.
10. Moro L, Battista C, Modricky C, Rovis L, de Bernard B. 1989 High-performance liquid chromatographic preparation of galactosyl-hydroxylysine, a specific bone collagen marker. J Chrom. 490:285-292.
11. Black D, Duncan A, Robins SP. 1988 Quantitative analysis of pyridinium crosslinks of collagen in urine using ion-paired reverse-phase high-performance liquid chromatography. Anal Biochem. 169:197-203.
12. Kamel S, Brazier M, Desmet G, Picard C, Mennecier I, Sebert JI. 1992 High-performance liquid chromatographic determination of 3-hydroxypyridinium derivatives as new markers of bone resorption. J Chrom. 574:255-260.
13. Heinegard D, Tiderstroem G. 1973 Determination of serum creatinine by direct colorimetric method. Clin Chim Acta. 43:303-310.
14. Hanley JA, McNeil BJ. 1983 A method of comparing the areas under receiver operated characteristic curves derived from the same cases. Radiology 148: 839-843.
15. Cary NC, ed. 1988 SAS-STAT. User's Guides, Cary, NC. SAS Institute, Inc.
16. Royal H, McNeil BJ. 1978 The evaluation and impact of diagnostic test. In: Gottshalk A, Hoffer PB, Potchen EJ, eds. Diagnostic Nuclear Medicine. Baltimore: Williams and Wilkins; pp 15-30.
17. Consensus Development Conference. 1993 Diagnosis, prophylaxis, and treatment of osteoporosis. Am J Med. 94:646-650.
18. Odvina CV, Wergedal JE, Libanati CR, Schultz EE, Baylink DJ. 1988 Relationship between trabecular vertebral body density and fractures: a quantitative definition of spinal osteoporosis. Metabolism 37:221-228.
19. Eriksen EF, Holstein SF, Eastell R, Cedel SL, O'Fallon WM, Riggs BL. 1990 Cancellous bone remodelling in type 1 (postmenopausal) osteoporosis quantitative assessment of rates of formation, resorption and bone loss at tissue and cellular levels. J Bone Miner Res. 5:311-319.
20. Askenasi R. 1975 Urinary excretion of free hydroxylysine, peptide-bound hydroxylysine and hydroxylysyl glycosides in physiological conditions. Clin Chim Acta. 59:87-92.
21. Beardsworth LJ, Eyre DR, Dickson IR. 1990 Changes with age in the urinary excretion of lysyl- and hydroxylysyl-piridinoline, two new markers of bone collagen turnover. J Bone Miner Res. 5:671-676.
22. Uebelhart D, Ginetys E, Chapuy MC, Delmas PD. 1990 Urinary excretion of pyridinium crosslinks: a new marker of bone resorption in metabolic bone diseases. Bone Miner. 8:87-96.
23. Moro L, Modricky C, Rovis L, de Bernard B. 1988 Determination of galactosyl hydroxylysine in urine as a means for the identification of osteoporotic women. Bone Miner. 3:271-276.
24. Uebelhart D, Schklemmer A, Johansen J, Ginetys E, Christiansen C, Delmas PD. 1991 Effect of menopause and hormone replacement therapy on the urinary excretion of pyridinium crosslinks. J Clin Endocrinol Metab. 72:367-373.
25. Bettica P, Moro L. 1993 Galactosyl hydroxylysine and deoxypyridinoline: a methodological comparison. Eur J Clin Chem Clin Biochem. 31:459-465.